Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19

Here we report our perspective on applying GapmeR technology in combination with recombinant angiotensin-converting enzyme 2 (ACE2) in the treatment of COVID-19 patients. GapmeR is a cell-permeating antisense single-stranded DNA molecule that can be designed to specifically target intracellular seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Navin Kumar, Fazil, Mobashar Hussain Urf Turabe, Duggan, Shane P., Kelleher, Dermot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427089/
https://www.ncbi.nlm.nih.gov/pubmed/32850978
http://dx.doi.org/10.3389/fmolb.2020.00197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427089/
https://www.ncbi.nlm.nih.gov/pubmed/32850978
http://dx.doi.org/10.3389/fmolb.2020.00197

Ejemplares similares